retatrutide phase 2 nejm 2023 obesity trial jastreboff Another Promising Medication (Retatrutide) for 𧬠The Future of Weight
Description
When to seek help red flags: Contact your GP or trial clinician promptly if you experience persistent or worsening nausea and vomiting, are unable to keep fluids down for more than 24 hours, or notice significant unintentional weight loss or difficulty maintaining adequate nutrition
If you are ready to take the next step towards a healthier, more vibrant you, we invite you to explore our offerings
Importantly, GLP-1 is not exceptional in its underlying biology
Practical Pain Management
Our clinic offers treatments that are carefully tailored to each individuals health profile and weight loss goals
